The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-3-(1-(5-bromo-4-(4-(trifluoromethyl)phenyl)oxazol-2-yl)-2-(5-methyl-1,3,4-oxadiazol-2-yl)ethoxy)-2,6-difluorobenzamide ID: ALA3098684
PubChem CID: 72947707
Max Phase: Preclinical
Molecular Formula: C22H14BrF5N4O4
Molecular Weight: 573.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nnc(CC(Oc2ccc(F)c(C(N)=O)c2F)c2nc(-c3ccc(C(F)(F)F)cc3)c(Br)o2)o1
Standard InChI: InChI=1S/C22H14BrF5N4O4/c1-9-31-32-15(34-9)8-14(35-13-7-6-12(24)16(17(13)25)20(29)33)21-30-18(19(23)36-21)10-2-4-11(5-3-10)22(26,27)28/h2-7,14H,8H2,1H3,(H2,29,33)
Standard InChI Key: SPZSYUHLFVIQFN-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
25.0674 -13.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0662 -13.9234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7743 -14.3324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4839 -13.9230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4811 -13.1003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7725 -12.6951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3596 -12.6955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3594 -11.8783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6520 -13.1043 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3582 -14.3315 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.7700 -11.8779 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.1873 -12.6891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8965 -13.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6027 -12.6837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3521 -13.0181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6867 -11.8755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4853 -11.7025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8953 -12.4095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8144 -10.9570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6281 -10.8704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9583 -10.1237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4759 -9.4630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6595 -9.5539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3330 -10.3007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8051 -8.7151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6174 -8.6262 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.3219 -8.0560 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.0120 -7.9202 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.7083 -12.4924 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
27.8996 -13.9122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6088 -14.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6978 -15.1271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.4977 -15.2939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9037 -14.5846 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3545 -13.9795 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8329 -16.0392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 2 0
7 9 1 0
2 10 1 0
6 11 1 0
5 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 18 1 0
17 16 1 0
16 14 2 0
17 18 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
17 19 1 0
22 25 1 0
25 26 1 0
25 27 1 0
25 28 1 0
18 29 1 0
13 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 31 2 0
33 36 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 573.27Molecular Weight (Monoisotopic): 572.0119AlogP: 5.55#Rotatable Bonds: 7Polar Surface Area: 117.27Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.96CX Basic pKa: ┄CX LogP: 3.42CX LogD: 3.42Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.29Np Likeness Score: -1.19
References 1. Stokes NR, Baker N, Bennett JM, Chauhan PK, Collins I, Davies DT, Gavade M, Kumar D, Lancett P, Macdonald R, Macleod L, Mahajan A, Mitchell JP, Nayal N, Nayal YN, Pitt GR, Singh M, Yadav A, Srivastava A, Czaplewski LG, Haydon DJ.. (2014) Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ., 24 (1): [PMID:24287381 ] [10.1016/j.bmcl.2013.11.002 ]